A detailed history of J. Goldman & CO LP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 72,541 shares of AVNS stock, worth $1.16 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
72,541
Previous 72,541 -0.0%
Holding current value
$1.16 Million
Previous $1.45 Million 20.62%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$17.85 - $20.42 $250,167 - $286,186
-14,015 Reduced 16.19%
72,541 $1.45 Million
Q1 2024

May 15, 2024

SELL
$17.97 - $22.68 $2.7 Million - $3.4 Million
-150,098 Reduced 63.43%
86,556 $1.72 Million
Q4 2023

Feb 14, 2024

BUY
$17.64 - $22.99 $97,408 - $126,950
5,522 Added 2.39%
236,654 $5.31 Million
Q3 2023

Nov 14, 2023

BUY
$19.93 - $26.31 $4.61 Million - $6.08 Million
231,132 New
231,132 $4.67 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.